Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,149 | -17,038 | -7,030 | -13,335 | -13,598 |
| Depreciation Amortization | 1,468 | 978 | 489 | 1,963 | 1,473 |
| Accounts payable and accrued liabilities | 801 | 806 | 324 | 249 | 612 |
| Other Working Capital | 1,474 | 859 | 181 | 82 | 921 |
| Other Operating Activity | 107 | 6,815 | 2,349 | -642 | 2,645 |
| Operating Cash Flow | $-12,299 | $-7,580 | $-3,687 | $-11,683 | $-7,947 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 500 | N/A | N/A | N/A | N/A |
| PPE Investments | -16 | -16 | -10 | -8 | -6 |
| Other Investing Activity | -59 | 0 | 0 | -172 | 0 |
| Investing Cash Flow | $425 | $-16 | $-10 | $-180 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | N/A | 16,302 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 1,525 | 1,525 |
| Financing Cash Flow | $0 | $0 | $0 | $17,827 | $1,525 |
| Beginning Cash Position | 23,099 | 23,099 | 23,099 | 17,135 | 17,135 |
| End Cash Position | 11,225 | 15,503 | 19,402 | 23,099 | 10,239 |
| Net Cash Flow | $-11,874 | $-7,596 | $-3,697 | $5,964 | $-6,896 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,299 | -7,580 | -3,687 | -11,683 | -7,947 |
| Capital Expenditure | -16 | -16 | -10 | -8 | -6 |
| Free Cash Flow | -12,315 | -7,596 | -3,697 | -11,691 | -7,953 |